Spruce Biosciences, Inc. Accounts Payable
Spruce Biosciences, Inc. (SPRB) had Accounts Payable of $1.21 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-12
- 2026-06-30: Accounts Payable, Current $1.21M.
- 2026-03-31: Accounts Payable, Current $2.68M.
- 2025-12-31: Accounts Payable, Current $943.00K.
- 2025-09-30: Accounts Payable, Current $1.39M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $1.21M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $2.68M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $943.00K 10-Q · filed 2026-08-12 |
| 2025-09-30 | $1.39M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $807.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $1.88M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $1.29M 10-K · filed 2026-03-09 |
| 2024-09-30 | $1.80M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $682.00K 10-Q · filed 2024-08-12 |
| 2024-03-31 | $1.89M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $3.33M 10-K · filed 2025-04-15 |
| 2023-09-30 | $3.15M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $945.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $3.45M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $1.43M 10-K · filed 2024-03-18 |
| 2022-09-30 | $2.18M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $1.45M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $1.11M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $2.82M 10-K · filed 2023-03-16 |
| 2021-09-30 | $2.13M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $1.11M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $2.57M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $3.63M 10-K · filed 2022-03-14 |
| 2020-09-30 | $4.00M 10-Q · filed 2020-11-18 |
| 2019-12-31 | $1.88M 10-K · filed 2021-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |